Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

JFrog stock falls about 3% today as year-end tech dip hits software names

JFrog stock falls about 3% today as year-end tech dip hits software names

NEW YORK, December 31, 2025, 12:50 ET — Regular session JFrog Ltd (FROG.O) shares fell 3.2% to $63.35 by midday in New York, after opening at $65.24 and hitting an intraday low of $62.72. The stock was trading in a $62.72 to $65.53 range. The move came as U.S. equities drifted lower in holiday-thinned trading on the final session of 2025, with technology stocks among the heavier weights. “Describing 2025 as ‘resilient’ might be an understatement,” Adam Turnquist, chief technical strategist at LPL Financial, said. Reuters Benchmark ETFs tracking the S&P 500 and Nasdaq were both modestly lower, underscoring a
31 December 2025
····
Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

NEW YORK, December 31, 2025, 11:55 ET — Regular session Shares of Cogent Biosciences slid on Wednesday, paring losses from earlier in the session, after the biotech disclosed a key regulatory filing while investors digested a cluster of insider stock sales. The stock was down 2.5% at $36.19, after touching a low of $34.33. The move comes as Cogent shifts from late-stage data to the U.S. Food and Drug Administration review process — a step that can widen the audience beyond biotech specialists and pull more short-term traders into the name. A New Drug Application, or NDA, is the formal
31 December 2025
·····
AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

NEW YORK, Dec 31, 2025, 12:20 ET — Regular session. AAON shares were down 2.7% at $76.48 in midday trade on Wednesday, after touching $79.67 earlier in the session. The move came two days after AAON disclosed it increased borrowing capacity on its existing credit facility to $600 million by exercising a previously available $100 million “accordion” feature — an option that lets borrowers expand a credit line under agreed terms. SEC Why it matters now: credit capacity tends to draw scrutiny when rates are still elevated and investors are quick to punish any sign that cash needs are rising
31 December 2025
·····
BKV stock slides as natural gas tumbles again — what traders are watching next

BKV stock slides as natural gas tumbles again — what traders are watching next

NEW YORK, December 31, 2025, 12:25 PM ET — Regular session BKV Corp shares slipped on Wednesday as the latest leg lower in U.S. natural gas prices weighed on sentiment across gas-linked producers. The stock was down about 2.6% at around $27.10 in midday trading, after touching $27.00. Why it matters now: natural gas has been driving the near-term tape for U.S. gas-heavy names, and the commodity moved sharply again into year-end. Henry Hub futures were last indicated down roughly 4.5% on the day, according to CME pricing. CME Group That kind of swing can quickly reset expectations for cash
31 December 2025
·····
LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

NEW YORK, Dec 31, 2025, 12:13 ET — Regular session LandBridge Company LLC shares slid on Wednesday and briefly set a new 52-week low, extending a late-year pullback as investors weighed a weaker crude backdrop and a risk-off tone in energy-linked pockets of the market. Investing.com The stock was down 3.2% at $48.63 in midday trading, after touching an intraday low of $48.29 — below the prior 52-week floor flagged in market reports. Investing.com+1 The move matters now because LandBridge’s business is tied to activity in the Permian Basin through surface and related revenue streams, leaving sentiment sensitive to the
31 December 2025
·
Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

NEW YORK, December 31, 2025, 11:38 ET — Regular session Shares of Xometry Inc fell about 3.5% to $60.94 in midday trading on Wednesday, after closing at $63.14 in the prior session. The Nasdaq-listed stock traded as high as $63.94 and as low as $60.58. The drop outpaced a modest retreat in U.S. equities on the final trading day of 2025, with broad indexes edging lower in thin holiday liquidity ahead of markets’ New Year’s Day closure. Reuters Year-end repositioning has been a focus for investors as 2026 approaches. “It’s just a healthy rebalancing of allocations,” Mark Hackett, chief market
31 December 2025
······
MIAX slides as year-end trading thins — what traders are watching next

MIAX slides as year-end trading thins — what traders are watching next

NEW YORK, December 31, 2025, 12:19 ET — Regular session. Miami International Holdings, Inc. shares were down 2.2% on Wednesday midday, a softer tape in thin, year-end trading for the exchange operator. The stock last traded at $44.70, down $0.99 from the previous close, after moving between $44.05 and $46.00 in the session. (https://www.marketwatch.com/investing/stock/miax) MarketWatch Why it matters now: MIAX has become a closely watched “picks-and-shovels” bet on derivatives activity — and into the final sessions of the year, investors often focus less on new headlines and more on positioning, liquidity and supply-demand shifts in recently listed names. Reuters There
31 December 2025
····
Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

NEW YORK, December 31, 2025, 11:51 ET — Regular session Regencell Bioscience Holdings Limited shares were down 4.8% at $21.79 as of 11:51 a.m. ET, after trading between $21.44 and $23.11 in a choppy session. The move came without any new company announcements. Regencell’s investor-relations site lists its most recent press release dated Oct. 31, and the latest SEC filing on EDGAR is its annual report filed the same day. Regencell Bioscience -+1 The pullback also tracked a softer tape across Wall Street on the final trading day of 2025, with trading volumes muted heading into the New Year’s holiday.
31 December 2025
····
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

NEW YORK, December 31, 2025, 11:38 ET — Regular session Genmab A/S (GMAB) shares slid on Wednesday, down about 3.3% at $30.44 in New York trading, as investors weighed a late-stage pipeline cut and the closing steps of a major acquisition. The Nasdaq-listed ADR touched $30.36 after opening at $31.42. Genmab said on Dec. 29 it will discontinue further clinical development of acasunlimab following a portfolio review and said the move does not change its full-year 2025 financial guidance. “Although the data have been encouraging, the compelling opportunities we see in our late‑stage pipeline led us to focus our investments,”
31 December 2025
·····
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

NEW YORK, December 31, 2025, 11:19 ET — Regular session Abivax Société Anonyme’s U.S.-listed American depositary shares (ABVX) fell about 3.8% to $133.04, down roughly $5.30 from Tuesday’s close, in late morning trade on Wednesday. The shares opened at $138 and swung between $132.13 and $140.25, with about 348,000 shares traded. The pullback keeps the spotlight on ABVX after takeover chatter earlier this month. Reuters reported on Dec. 10 that Abivax jumped on market rumours that Eli Lilly could make an offer, and Stifel analyst Damien Choplain said the “share price movement is driven by speculation around a possible takeover.”
31 December 2025
····
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

NEW YORK, December 31, 2025, 11:28 ET Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted on Wednesday, with the reason listed as “not available” as of 10:23 a.m. ET, according to a Reuters market notice. TradingView The halt matters because it prevents investors from buying or selling the shares while they wait for clarity, a bigger issue in thin year-end trading when price swings can be sharper once a stock reopens. Nasdaq normally assigns a code when it pauses trading — including “news pending,” used when material news is expected, and “additional information requested,” which can follow a
31 December 2025
··
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

NEW YORK, December 31, 2025, 11:12 ET — Regular session Life360, Inc. shares were down 4.4% at $63.79 in morning trading, after moving between $63.79 and $67.05. The Nasdaq-listed stock was off $2.94 from Tuesday’s close and had traded about 108,000 shares. The move comes as investors close the books on the final trading day of 2025, a stretch that often brings thinner liquidity and sharper price swings in smaller growth stocks. Wall Street’s major indexes were slightly lower and tech stocks extended losses as markets looked ahead to the path of U.S. interest rates into 2026. “The economy showed
31 December 2025
······
1 … 460 461 462 463 464 … 880

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop